Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov
Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
FaegreBD Consulting

2. Address

Address1
1050 K STREET NW
Address2
​SUITE 400
City
WASHINGTON
State
DC
Zip Code
20001
Country
USA

3. Principal place of business (if different than line 2)

City
State
Zip Code
Country

4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​KEN BEAVER
​2023127440
​brittany.stele@faegrebd.com
5. Senate ID#
​34158-1004886
7. Client Name Self Check if client is a state or local government or instrumentality
​PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE
6. House ID#
​301240263
TYPE OF REPORT 8. Year
​2013
Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​130,000.00
$5,000 or more $
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: David R. Zook, Chair
Date
07/18/2013

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

17. House(s) of Congress and Federal agencies Check if None

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
City
State
Zip Code
Country

21. Client new principal place of business (if different than line 20)

City
State
Zip Code
Country

22. New General description of client’s business or activities


LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​Elizabeth
​Baney
31
2
​Philip
​Bonforte
32
3
33
4
34
5
35
6
36
7
37
8
38
9
39
10
40
11
41
12
42
13
43
14
44
15
45
16
46
17
47
18
48
19
49
20
50
21
51
22
52
23
53
24
54
25
55
26
56
27
57
28
58
29
59
30
60

ISSUE UPDATE

24. General lobbying issue that no longer pertains


AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
Amerisource Bergen Corp
501 Patriot Pkwy
Roanoke TX 76262 USA
City
State Country
Novartis Pharmaceutical
One Health Plaza
East Hanover NJ 07936 USA
City
State Country
Boehringer Ingelheim Pharmaceutical
900 Ridgebury Rd
Ridgefield CT 06877 USA
City
State Country
Generic Pharmaceutical Assoc
777 Sixth St. NW Suite 510
Washington DC 20001 USA
City
State Country
Abbvie
200 Abbott Park Rd. J48-GS85
Abbott Park IL 60064 USA
City
State Country
Medline Industries, Inc
One Medline Place
Mundelain IL 60060 USA
City
State Country
PhRMA
950 F St. NW Suite 300
Washington DC 20004 USA
City
State Country
Mylan Pharmaceuticals
1401 K St. NW Suite 800
Washington DC 20005 USA
City
State Country
UPS
316 Pennsylvania Ave. SE Suite 300
Washington DC 20003 USA
City
State Country
Amylin Pharmaceuticals
1401 Eye St. NW Suite 330
Washington DC 20005 USA
City
State Country
Eli Lilly and Company
555 12th St. NW Suite 650
Washington DC 20004 USA
City
State Country
Takeda Pharma North America Inc
One Takeda Pkwy
Deerfield IL 60015 USA
City
State Country
L. Perrigo Company
515 Eastern Ave
Allegan MI 49101 USA
City
State Country
Johnson and Johnson
PO Box 16517
New Brunswick NJ 08906 USA
City
State Country
Bayer Healthcare Pharma Inc
PO Box 207
Pittsburgh PA 15230 USA
City
State Country
DSC Logistics
1750 South Wolf Rd
Des Plaines IL 60018 USA
City
State Country
AstraZeneca Pharmaceuticals LP
1800 Concord Pike
Wilmington DE 19850 USA
City
State Country
Cardinal Health
7000 Cardinal Place
Dublin OH 43017 USA
City
State Country
BIO
1201 Maryland Ave Suite 900
Washington DC 20024 USA
City
State Country
Genentech
7100 Riverport Dr
Louisville KY 40258 USA
City
State Country
Intl Warehouse Logistics Assoc
2800 S. River Rd
Des Plaines IL 60018 USA
City
State Country
Natl Assoc of Chain Drug Stores
413 N. Lee St.
Alexandria VA 22314 USA
City
State Country
Actavis
60 Columbia Rd. Building B
Morristown NJ 07960 USA
City
State Country
Pfizer
235 East 42nd St.
New York NY 10017 USA
City
State Country
Walgreens
1399 New York Ave. NW Suite 725
Washington DC 20005 USA
City
State Country
Healthcare Distrib Mngmt Assoc
901 Glebe Rd. Suite 1000
Arlington VA 22203 USA
City
State Country
Health Industry Distrib Assoc
310 Montgomery St.
Alexandria VA 22314 USA
City
State Country
Mallinckrodt (Covidien)
675 McDonnell Blvd
St. Louis MO 63042 USA
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 16 31
2 17 32
3 18 33
4 19 34
5 20 35
6 21 36
7 22 37
8 23 38
9 24 39
10 25 40
11 26 41
12 27 42
13 28 43
14 29 44
15 30 45

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country)
Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 31 61
2 32 62
3 33 63
4 34 64
5 35 65
6 36 66
7 37 67
8 38 68
9 39 69
10 40 70
11 41 71
12 42 72
13 43 73
14 44 74
15 45 75
16 46 76
17 47 77
18 48 78
19 49 79
20 50 80
21 51 81
22 52 82
23 53 83
24 54 84
25 55 85
26 56 86
27 57 87
28 58 88
29 59 89
30 60 90